NSP Insperity posts 51 percent positive EPS surprise for first quarter 2026 shares rise 358 percent today GMTL Guardian shares plunge 838 as Q3 loss widens with zero revenue reported Vertex Pharmaceuticals Incorporated VRTX Price Target Raised by RBC Amid Positive Regulatory Milestones and Biotech Sector Tailwinds QNC Quantum reports 1117B revenue but Q1 loss widens shares fall 177 amid profitability concerns Blackstone and Google Launch 5 Billion Neocloud Joint Venture Targeting AI Compute Demand SpaceX Taps Goldman Sachs to Lead Anticipated RecordBreaking IPO Apogee Thera APGE Reports Strong Q1 2026 Revenue NA EPS Beats Jensen Huang Joins Trumps China Trip After Presidents Personal Call to Nvidia CEO Futures Edge Higher After Market Milestone Select Stocks Signal Potential Upside TrumpConnected Stock Trades Draw Scrutiny Over Potential Conflicts Earnings Season in Focus Navigating the Calendar and Analyst Consensus SP 500 Hits New High as Healthcare and Tech Lead Utilities Slump JEPQs High Distribution Yield Unpacking the ELN Counterparty Risk Wealth Concealment Among Peers The Social and Financial Implications of Pretending to Be Broke DoorDash Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher NP Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Gains WTW Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Edges Lower Deere Company Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported AES Q1 2026 Earnings EPS Surges 80 Above Estimates Stock Flat Genius Sports GENI Edges Higher as Stock Holds Above Key Support Huntington Ingalls Industries HII Slips 11 as Defense Sector Faces Mixed Signals Nucor Corporation NUE Gains 36 as Steel Sector Momentum Builds Oatly OTLY Holds Steady Near Support as PlantBased Sector Faces Headwinds Avino Silver Gold Mines ASM Gains 74 Amid Silver Sector Strength Barclays Posts 18 Profit Increase Raises FullYear Income Outlook STOK Q1 2026 Earnings EPS Surprises to the Upside as Clinical Pipeline Advances Cardlytics CDLX Slips 495 as Stock Hovers Near Support at 066